I.R.C.C.S. OSPEDALE SAN RAFFAELE

Clinical Partner

San Raffaele University and Research Hospital (OSR) is one of the leading private scientific research institutes in Italy. It comprises both clinical and research activities, conducted by a highly specialized and qualified Hospital with around 1,600 basic, clinical and translational scientists. OSR integrates its research with the education and training activities conducted within Vita-Salute San Raffaele University (UniSR). OSR and UniSR are completed by Centro San Raffaele Foundation (FCSR), a non-profit organization that has been established to support the research of the IRCCS San Raffaele with the aim of helping the development of science in the service of medicine All together compose the San Raffaele Scientific Institute (SRSI), which hosts all the clinical, teaching and research activities in a large infrastructural compound. OSR performs cutting-edge science and aims at advancing the knowledge about human diseases and novel therapies through translational research (http://www.hsr.it/research/). The Breast Unit is certified according to UNI-EN-ISO 9001 since 2016 and is made up of a strong multidisciplinary team of researchers and physicians working to provide a personalized and unique diagnostic and therapeutic path. Every year around 500 breast cancer patients are operated in OSR. OSR will be actively involved in the preparation of CANKADO with the relevant information during the first year and in WP4 contributing to patient enrolment, data acquisition, patient training and data analysis. Furthermore, OSR will contribute to WP6 dissemination activities and public affairs and will contribute to all other workpackages. Oreste Gentilini the team coordinator at San Raffaele is a well-known breast surgeon principal investigator of outstanding breast cancer trials and actual CEO of the EU Breast Network a non-profit network of renowned oncological breast surgeons is to join forces throughout Europe to accelerate scientific progress to the direct benefit of breast cancer patients.

Partner Team Members

This project has received funding from the European Union's Horizon Europe research and innovation programme under Grant Agreement number 101057389